Modulation Therapeutics, Inc.
Clinical trials sponsored by Modulation Therapeutics, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Radioactive drug trial aims at rare eye cancer Results expected Mar 2027 (estimated)